NEW INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. & Encourage...
June 13 2018 - 1:10PM
Business Wire
The Schall Law Firm, a national shareholder rights litigation
firm, announces that it is investigating claims on behalf of
investors of Akers Biosciences, Inc. ("Akers" or the "Company")
(NASDAQ: AKER) for violations of §§10(b) and 20(a) of the
Securities Exchange Act of 1934 and Rule 10b-5 promulgated
thereunder by the U.S. Securities and Exchange Commission.
The investigation focuses on whether the Company issued false
and/or misleading statements and/or failed to disclose information
pertinent to investors. On May 21, 2018, Akers announced that it
was unable to file its Form 10-Q quarterly report with the SEC for
the period ending March 31, 2018. The Company added that its
internal review has expanded to include the “characterization of
certain revenue recognition items . . . now includes certain
transactions in previous quarters.” On May 22, 2018, shares of
Akers fell more than 8% based on this news. On May 29, 2018, Akers
announced that “Raymond F. Akers Jr., Ph.D. has resigned as a
director of the Company with immediate effect.” Akers shares fell
33% the same day based on this announcement. On June 1, the Company
released a letter to the SEC from Dr. Raymond Akers stating that he
“resigned from the Board of Directors due to significant
differences regarding the policies and practices of the Board of
Directors, accounting and business practices of Management, and new
Counsel.”
If you are a shareholder who suffered a loss, click here to
participate.
We also encourage you to contact Brian Schall, or Sherin
Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite
404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights
free of charge. You can also reach us through the firm's website
at www.schallfirm.com, or by email
at brian@schallfirm.com.
The class in this case has not yet been certified, and until
certification occurs, you are not represented by an attorney. If
you choose to take no action, you can remain an absent class
member.
The Schall Law Firm represents investors around the world and
specializes in securities class action lawsuits and shareholder
rights litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and rules of
ethics.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180613006008/en/
The Schall Law FirmBrian Schall, Esq.Sherin Mahdavian,
Esq.310-301-3335info@schallfirm.comwww.schallfirm.com
Akers Biosciences (NASDAQ:AKER)
Historical Stock Chart
From Mar 2024 to Apr 2024
Akers Biosciences (NASDAQ:AKER)
Historical Stock Chart
From Apr 2023 to Apr 2024